EMPAVELI (pegcetacoplan) | Patient Informational Website
EMPAVELI is a medicine that affects your immune system and may lower the ability of your immune system to fight infections. EMPAVELI increases your chance of getting serious …
For C3G or primary IC-MPGN | EMPAVELI® (pegcetacoplan)
EMPAVELI is a medicine that affects your immune system and may lower the ability of your immune system to fight infections. EMPAVELI increases your chance of getting serious …
For treating adults with PNH | EMPAVELI® (pegcetacoplan)
Explore EMPAVELI and discover what's possible for adults with paroxysmal nocturnal hemoglobinuria (PNH).
Possible Side effects | EMPAVELI® (pegcetacoplan)
Review important safety information for EMPAVELI, including possible side effects in adults with paroxysmal nocturnal hemoglobinuria (PNH).
How It Works | EMPAVELI® (pegcetacoplan)
EMPAVELI is a medicine that affects your immune system and may lower the ability of your immune system to fight infections. EMPAVELI increases your chance of getting serious …
Hemolysis in PNH | EMPAVELI® (pegcetacoplan)
Find out what hemolysis is , its connection with paroxysmal nocturnal hemoglobinuria (PNH) symptoms, and the impact of treatments on hemolysis.
ApellisAssist® Program | EMPAVELI® (pegcetacoplan)
EMPAVELI increases your chance of getting serious infections caused by encapsulated bacteria such as Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae type …
About EMPAVELI | EMPAVELI® (pegcetacoplan)
EMPAVELI is a medicine that affects your immune system and may lower the ability of your immune system to fight infections. EMPAVELI increases your chance of getting serious …
Self-administration with EMPAVELI | EMPAVELI® (pegcetacoplan)
EMPAVELI increases your chance of getting serious infections caused by encapsulated bacteria such as Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae type …
Tools for Your Journey | EMPAVELI® (pegcetacoplan)
The most common side effects in adults and children 12 years of age and older with C3G or primary IC-MPGN treated with EMPAVELI include injection-site reactions, fever, common cold, …